Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Innovative approaches in MRI technology demonstrate the potential of portable ultra-low-field brain imaging to assist in improving brain health
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking medical device company that has redefined brain imaging with the world's first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system—the Swoop® system—today announced that three scientific sessions highlighting ultra-low-field imaging data will be presented at the Radiological Society of North America (RSNA) 2023 Annual Meeting in Chicago. These studies analyzed how portable MR brain imaging may assist physicians in the diagnosis and management of neurological conditions in critical care settings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231120443877/en/
Conference attendees can learn more during the presentations listed below.
Name:Longitudinal Relaxivity Estimation of Gadolinium-based Contrast Agents at 64 mT
Presented by: Sudarshan Ragunathan, PhD
Session: Physics Tuesday Poster Discussions II | T5B-SPPH
Date and time: Tuesday, November 28, 12:45 PM–1:15 PM CST
Location: Learning Center
Name:A Generative Adversarial Network Approach for Low-field to High-field Image Translation
Presented by: Alfredo Lucas
Session: Neuroradiology (Techniques and Methods: AI for Image Acquisition) | W3-SSNR10
Date and time: Wednesday, November 29, 9:30 AM–10:30 AM CST
Location: E353C
Name: Point-of-care Brain MRI: Update on Preliminary Results from a Single-center Retrospective Study in the Neurocritical Care Setting
Presented by: Brian Gerard Yep, MD
Session: Neuroradiology (Techniques and Methods: Diffusion, Perfusion, and Other Techniques) | W7-SSNR12
Date and time: Wednesday, November 29, 3:00 PM–4:00 PM CST
Location: E353B
"At Hyperfine, Inc., we strive to push the boundaries of medical technology to make MR brain imaging more accessible, and our presence at RSNA 2023 underscores the promise of expanded use cases for portable MR brain imaging technology," said Chip Truwit, MD, Hyperfine, Inc. vice president of scientific affairs. "We'll continue to prioritize clinical application research for the Swoop system because expanding access to portable MR brain imaging is critical in improving how patient care is delivered."
For more information about the Swoop® Portable MR Imaging® System, please visit hyperfine.io.
Posted In: HYPR